Weight Loss During Initial Chemotherapy Predicts Survival in Patients With Advanced Gastric Cancer

References

• Elimova E, Shiozaki H, Wadhwa R, Sudo K, Chen Q, et al.: Medical management of gastric cancer: a 2014 update. World J Gastroenterol 20, 13637–13647, 2014.
   PubMed Web of Science ®Google Scholar
• Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, et al.: Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of her2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): A phase 3, open-label, randomised controlled trial. Lancet 376, 687–697, 2010.
   PubMed Web of Science ®Google Scholar
• Koizumi W, Narahara H, Hara T, Takagane A, Akiya T, et al.: S-1 plus cisplatin versus s-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): A phase III trial. Lancet Oncol 9, 215–221, 2008.
   PubMed Web of Science ®Google Scholar
• Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, et al.: Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 69, 491–497, 1980.
   PubMed Web of Science ®Google Scholar
• Andreyev HJ, Norman AR, Oates J, and Cunningham D: Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer 34, 503–509, 1998.
   PubMed Web of Science ®Google Scholar
• Ravasco P, Monteiro-Grillo I, Vidal PM, and Camilo ME: Cancer: Disease and nutrition are key determinants of patients' quality of life. Support Care Cancer 12, 246–252, 2004.
   PubMed Web of Science ®Google Scholar
• McGeer AJ, Detsky AS, and O'Rourke K: Parenteral nutrition in cancer patients undergoing chemotherapy: A meta-analysis. Nutrition 6, 233–240, 1990.
   PubMed Web of Science ®Google Scholar
• Strasser F: Eating-related disorders in patients with advanced cancer. Support Care Cancer 11, 11–20, 2003.
   PubMed Web of Science ®Google Scholar
• Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 2011. doi: 10.1007/s10120-011-0041-5.
   Web of Science ®Google Scholar
• McMillan DC, Crozier JE, Canna K, Angerson WJ, and McArdle CS: Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Colorectal Dis 22, 881–886, 2007.
   PubMed Web of Science ®Google Scholar
• Ross PJ, Ashley S, Norton A, Priest K, Waters JS, et al.: Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers? Br J Cancer 90, 1905–1911, 2004.
   PubMed Web of Science ®Google Scholar
• Lu Z, Yang L, Yu J, Lu M, Zhang X, et al.: Change of body weight and macrophage inhibitory cytokine-1 during chemotherapy in advanced gastric cancer: what is their clinical significance? Pros One 9, e88553, 2014.
   PubMed Web of Science ®Google Scholar
• Ock CY, Oh DY, Lee J, Kim TY, Lee KH, et al.: Weight loss at the first month of palliative chemotherapy predicts survival outcomes in patients with advanced gastric cancer. Gastric Cancer, 2015.
   Web of Science ®Google Scholar
• Jones PJL, A positive approach to nutrition as treatment. Report of a working party chaired by Professor JE Lennard Jones. London, Kings Fund Centre, 1992.
   Google Scholar
• Zimmerman MA, Selzman CH, Cothren C, Sorensen AC, Raeburn CD, et al.: Diagnostic implications of C-reactive protein. Arch Surg 138, 220–224, 2003.
   PubMedGoogle Scholar
• Koike Y, Miki C, Okugawa Y, Yokoe T, Toiyama Y, et al.: Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer. J Surg Oncol 98, 540–544, 2008.
   PubMed Web of Science ®Google Scholar
• Scott HR, McMillan DC, Crilly A, McArdle CS, Milroy R.: The relationship between weight loss and interleukin 6 in non-small-cell lung cancer. Br J Cancer 73, 1560–1562, 1996.
   PubMed Web of Science ®Google Scholar
• McMillan DC, Scott HR, Watson WS, Preston T, Milroy R, et al.: Longitudinal study of body cell mass depletion and the inflammatory response in cancer patients. Nutr Cancer 31, 101–105, 1998.
   PubMed Web of Science ®Google Scholar
• Maltoni M, Caraceni A, Brunelli C, Broeckaert B, Christakis N, et al.: Prognostic factors in advanced cancer patients: Evidence-based clinical recommendations—a study by the Steering Committee of the European Association for Palliative Care. J Clin Oncol 23, 6240–6248, 2005.
   PubMed Web of Science ®Google Scholar
• O'Gorman P, McMillan DC, and McArdle CS.: Prognostic factors in advanced gastrointestinal cancer patients with weight loss. Nutr Cancer 37, 36–40, 2000.
   PubMed Web of Science ®Google Scholar
• Scott HR, McMillan DC, Forrest LM, Brown DJ, McArdle CS, et al.: The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer. Br J Cancer 87, 264–267, 2002.
   PubMed Web of Science ®Google Scholar
• Proctor MJ, Morrison DS, Talwar D, Balmer SM, O'Reilly DS, et al.: An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: A Glasgow Inflammation Outcome Study. Br J Cancer 104, 726–734, 2011.
   PubMed Web of Science ®Google Scholar
• McMillan DC: An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer. Proc Nutr Soc 67, 257–262, 2008.
   PubMed Web of Science ®Google Scholar
• Proctor MJ, Morrison DS, Talwar D, Balmer SM, Fletcher CD, et al.: A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study. Eur J Cancer 47, 2633–2641, 2011.
   PubMed Web of Science ®Google Scholar
• Argiles JM, Busquets S, Stemmler B, and Lopez-Soriano FJ: Cancer cachexia: understanding the molecular basis. Nat Rev Cancer 14, 754–762, 2014.
   PubMed Web of Science ®Google Scholar
• Fearon KC, Von Meyenfeldt MF, Moses AG, Van Geenen R, Roy A, et al.: Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut 52, 1479–1486, 2003.
   PubMed Web of Science ®Google Scholar
• Murphy RA, Mourtzakis M, Chu QS, Baracos VE, Reiman T, et al.: Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving chemotherapy. Cancer 117, 1775–1782, 2011.
   PubMed Web of Science ®Google Scholar
• Sanchez-Lara K, Turcott JG, Juarez-Hernandez E, Nunez-Valencia C, Villanueva G, et al.: Effects of an oral nutritional supplement containing eicosapentaenoic acid on nutritional and clinical outcomes in patients with advanced non-small cell lung cancer: randomised trial. Clin Nutr 33, 1017–1023, 2014.
   PubMed Web of Science ®Google Scholar